Literature DB >> 11518731

Generation of experimental allergic airways inflammation in the absence of draining lymph nodes.

B U Gajewska1, D Alvarez, M Vidric, S Goncharova, M R Stämpfli, A J Coyle, J C Gutierrez-Ramos, M Jordana.   

Abstract

The objective of this study was to investigate the contribution of secondary lymphoid organs in the generation and maintenance of experimental allergic airway inflammation. We employed a previously reported murine model of respiratory mucosal allergic sensitization, induced by repeated aerosolizations of ovalbumin in the context of a GM-CSF airway environment. We executed this protocol in wild-type (WT) and lymphotoxin-alpha-deficient mice (LTalpha-KO) mice, which are devoid of lymph nodes (LNs) and possess rudimentary spleen structures. Despite the lack of pulmonary LNs draining the airway compartment, LTalpha-KO mice were fully capable of mounting a robust inflammatory response in the airways, consisting of Th2 polarized CD4+ T cells and eosinophils. This was accompanied by IL-5, IL-13, and IFN-gamma production by splenocytes and generation of ovalbumin-specific serum IgE. Exposure to the same antigen 7 weeks after complete resolution of airway inflammation once again induced a Th2 polarized infiltrate, demonstrating intact immunological memory. To investigate inherent plasticity in establishing antigen-specific immunity, mice were splenectomized before sensitization. Allergic sensitization was completely abrogated in splenectomized LTalpha-KO mice, compared with eusplenic LTalpha-KO controls. These data demonstrate that secondary lymphoid organs, either LN or spleen, are essential for the generation of allergic airway responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518731      PMCID: PMC209400          DOI: 10.1172/JCI12627

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Antigen persistence is required for somatic mutation and affinity maturation of immunoglobulin.

Authors:  Y Wang; G Huang; J Wang; H Molina; D D Chaplin; Y X Fu
Journal:  Eur J Immunol       Date:  2000-08       Impact factor: 5.532

2.  Lymphotoxin-alpha-deficient mice can clear a productive infection with murine gammaherpesvirus 68 but fail to develop splenomegaly or lymphocytosis.

Authors:  B J Lee; S Santee; S Von Gesjen; C F Ware; S R Sarawar
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Conjugation of antibodies with fluorochromes: modifications to the standard methods.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

Review 4.  Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development.

Authors:  N H Ruddle
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

5.  Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation.

Authors:  B N Lambrecht; M De Veerman; A J Coyle; J C Gutierrez-Ramos; K Thielemans; R A Pauwels
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

6.  Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin.

Authors:  P De Togni; J Goellner; N H Ruddle; P R Streeter; A Fick; S Mariathasan; S C Smith; R Carlson; L P Shornick; J Strauss-Schoenberger
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

7.  Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice.

Authors:  M Matsumoto; S F Lo; C J Carruthers; J Min; S Mariathasan; G Huang; D R Plas; S M Martin; R S Geha; M H Nahm; D D Chaplin
Journal:  Nature       Date:  1996-08-01       Impact factor: 49.962

8.  Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness.

Authors:  T A Banks; B T Rouse; M K Kerley; P J Blair; V L Godfrey; N A Kuklin; D M Bouley; J Thomas; S Kanangat; M L Mucenski
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

9.  The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen.

Authors:  W Xia; C E Pinto; R L Kradin
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

10.  Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes.

Authors:  K Y Vermaelen; I Carro-Muino; B N Lambrecht; R A Pauwels
Journal:  J Exp Med       Date:  2001-01-01       Impact factor: 14.307

View more
  7 in total

Review 1.  The development and function of mucosal lymphoid tissues: a balancing act with micro-organisms.

Authors:  T D Randall; R E Mebius
Journal:  Mucosal Immunol       Date:  2014-02-26       Impact factor: 7.313

2.  Arhgef1 is required by T cells for the development of airway hyperreactivity and inflammation.

Authors:  Jeanette P Brown; Christian Taube; Nobuaki Miyahara; Toshiyuki Koya; Roberta Pelanda; Erwin W Gelfand; Raul M Torres
Journal:  Am J Respir Crit Care Med       Date:  2007-04-26       Impact factor: 21.405

3.  Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance.

Authors:  Pejman Soroosh; Taylor A Doherty; Wei Duan; Amit Kumar Mehta; Heonsik Choi; Yan Fei Adams; Zbigniew Mikulski; Naseem Khorram; Peter Rosenthal; David H Broide; Michael Croft
Journal:  J Exp Med       Date:  2013-04-01       Impact factor: 14.307

Review 4.  Tumor immunosurveillance in human cancers.

Authors:  Bernhard Mlecnik; Gabriela Bindea; Franck Pagès; Jérôme Galon
Journal:  Cancer Metastasis Rev       Date:  2011-03       Impact factor: 9.264

Review 5.  Bronchus-associated lymphoid tissue (BALT) structure and function.

Authors:  Troy D Randall
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

6.  Induction and effector phase of allergic lung inflammation is independent of CCL21/CCL19 and LT-beta.

Authors:  Corinne Ploix; Riaz I Zuberi; Fu-Tong Liu; Monica J Carson; David D Lo
Journal:  Int J Med Sci       Date:  2009-03-10       Impact factor: 3.738

7.  Lymphotoxin is required for maintaining physiological levels of serum IgE that minimizes Th1-mediated airway inflammation.

Authors:  Hyung-Sik Kang; Sarah E Blink; Robert K Chin; Youjin Lee; Oliver Kim; Joel Weinstock; Thomas Waldschmidt; Daniel Conrad; Bohao Chen; Julian Solway; Anne I Sperling; Yang-Xin Fu
Journal:  J Exp Med       Date:  2003-11-24       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.